Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CSL Ltd. Director's Dealing 2020

Mar 11, 2020

17854_rns_2020-03-11_f4a73c82-010b-42d3-9129-7d0402e6f8f5.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

12 March 2020

==> picture [205 x 32] intentionally omitted <==

==> picture [58 x 30] intentionally omitted <==

==> picture [262 x 27] intentionally omitted <==

For immediate release

Change of Director’s Interest Notice

CSL Limited (ASX:CSL; USOTC:CSLLY)

The attached Appendix 3Y relates to changes in the relevant interest in the Company’s securities held by the Chairman of CSL Limited, Dr Brian McNamee AO.

Dr McNamee has sold 10% of his holding, representing 17,758 shares. The proceeds of the sale will be used to meet personal, philanthropic and tax obligations.

Following this transaction, Dr McNamee continues to hold a significant interest in the Company’s securities, comprising 161,057 ordinary shares and he remains one of the Company’s largest private shareholders.

Further details are provided in the Appendix 3Y.

Fiona Mead Company Secretary and Head of Corporate Governance

FURTHER INFORMATION

For further information, please contact:

Investors: Mark Dehring Head of Investor Relations CSL Limited Telephone: +613 9389 3407 Email: [email protected]

Media: Christina Hickie Senior Manager Communications CSL Limited Mobile +61 429 609 762 Email: [email protected]

® Trademarks of CSL Limited or its affiliates.

==> picture [99 x 7] intentionally omitted <==

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity CSL Limited ABN 99 051 588 348

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Brian McNamee AO
Date of last notice 21 February 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest Indirect Interest
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. Custodian, Trustee and/or Nominee
Date of change 10 March 2020
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No of securities held prior to No of securities held prior to Direct: 0 Ordinar Shares* Direct: 0 Ordinar Shares* Direct: 0 Ordinar Shares* Direct: 0 Ordinar Shares*
No of securities held prior to change Direct: 0 Ordinar Shares*
. yIndirect:143,503* Ordinary Shares held byMutual Trust as custodian for Brian
McNamee25,000 Ordinary Shares held by
HSBC Bank Australia Ltd ascustodian for Brian McNamee9,084 Ordinary Shares held byMutual Trust as custodian for Brian
& Virginia McNamee Foundation1,187 Ordinary Shares held by
Solium Nominees (Australia) PtyLtd as custodian for Alalia Pty Ltd
41 Ordinary Shares held by SoliumNominees (Australia) Pty Ltd as
custodian for Brian McNamee.
Rights – 346 Rights held under the CSL
Limited Non-Executive Director Rights Plan(which commenced operation from 1 July2018) (the Plan).*due to an error in classification, shares previously disclosedas being held directly by Dr McNamee are now disclosed asbeing indirectly held. The total number of shares disclosedhas not changed.
Class (1)Ordinary Shares(2)Rights under the Plan - Subject tothe rules of the Plan, each Right carries theright to acquire one Ordinary Share.
Number acquired NA
Number disposed 17,758 Ordinary Shares
Value/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation An average price of $315.37
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change Indirect:
131,069 Ordinary Shares held by
Mutual Trust as custodian for Brian
McNamee
25,000 Ordinary Shares held by
HSBC Bank Australia Ltd as
custodian for Brian McNamee
3,760 Ordinary Shares held by
Mutual Trust as custodian for Brian
& Virginia McNamee Foundation
1,187 Ordinary Shares held by
Solium Nominees (Australia) Pty
Ltd as custodian for Alalia Pty Ltd
41 Ordinary Shares held by Solium
Nominees (Australia) Pty Ltd as
custodian for Brian McNamee
Rights – 346 Rights held under the Plan
Nature of change On Market Trade
Example: on-market trade, off-market trade, exercise of options, issue of
securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? No
If so, was prior written clearance provided to allow the tradeto proceed during this period?
If prior written clearance was provided, on what date was thisprovided?

Fiona Mead Company Secretary

12 March 2020

  • See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011